BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 38398130)

  • 1. Management of Intrahepatic Cholangiocarcinoma: A Narrative Review.
    Tsung C; Quinn PL; Ejaz A
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma.
    Bath NM; Pawlik TM
    Chin Clin Oncol; 2023 Feb; 12(1):5. PubMed ID: 36922354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma.
    Scott A; Wong P; Melstrom LG
    Surgery; 2023 Jul; 174(1):113-115. PubMed ID: 36906437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy.
    Turgeon MK; Maithel SK
    Chin Clin Oncol; 2020 Feb; 9(1):4. PubMed ID: 31500433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles.
    Beal EW; Cloyd JM; Pawlik TM
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review.
    Sposito C; Droz Dit Busset M; Virdis M; Citterio D; Flores M; Bongini M; Niger M; Mazzaferro V
    Eur J Surg Oncol; 2022 Jan; 48(1):150-159. PubMed ID: 34412956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeted and systemic therapy for intrahepatic cholangiocarcinoma: a multi-disciplinary approach.
    Merath K; Tiwari A; Parikh AA; Pawlik TM
    Future Oncol; 2023 Dec; 19(39):2607-2621. PubMed ID: 38108100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of surgical management of intrahepatic cholangiocarcinoma.
    Squires MH; Cloyd JM; Dillhoff M; Schmidt C; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):671-681. PubMed ID: 29911912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
    Maithel SK; Keilson JM; Cao HST; Rupji M; Mahipal A; Lin BS; Javle MM; Cleary SP; Akce M; Switchenko JM; Rocha FG
    Ann Surg Oncol; 2023 Oct; 30(11):6558-6566. PubMed ID: 37368098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies.
    Ruff SM; Pawlik TM
    Front Oncol; 2024; 14():1321683. PubMed ID: 38344197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Options for Systemic Therapies in Intrahepatic Cholangiocarcinoma (iCCA).
    Becht R; Wasilewicz MP
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma-A Narrative Review.
    Chamseddine S; LaPelusa M; Kaseb AO
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Treatment of Distal Cholangiocarcinoma.
    Gorji L; Beal EW
    Curr Oncol; 2022 Sep; 29(9):6674-6687. PubMed ID: 36135093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.
    Luvira V; Satitkarnmanee E; Pugkhem A; Kietpeerakool C; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD012814. PubMed ID: 34515993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma.
    Panayotova G; Guerra J; Guarrera JV; Lunsford KE
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34070772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review.
    Yoo C; Shin SH; Park JO; Kim KP; Jeong JH; Ryoo BY; Lee W; Song KB; Hwang DW; Park JH; Lee JH
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma.
    Chun YS; Javle M
    Cancer Control; 2017; 24(3):1073274817729241. PubMed ID: 28975832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of intrahepatic cholangiocarcinoma.
    Hewitt DB; Brown ZJ; Pawlik TM
    Expert Rev Anticancer Ther; 2022 Jan; 22(1):27-38. PubMed ID: 34730474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Landmark Series: Intrahepatic Cholangiocarcinoma.
    Cloyd JM; Ejaz A; Pawlik TM
    Ann Surg Oncol; 2020 Aug; 27(8):2859-2865. PubMed ID: 32419038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.